Arrowhead Research Corp. (ARWR)
|
1.89
-0.04 (-2.07%)
|
|
|
|
ARWR additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ARWR Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
Vanguard Extended Market Idx
iShares Russell Microcap Index
TFS Market Neutral
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Fidelity Spartan Extended Mkt Index Inv
SA US Small Company
Vanguard Balanced Index
Fidelity Nasdaq Composite Index Tracking
Fidelity Nasdaq Composite Index
iShares Russell Microcap Index
TFS Market Neutral
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Fidelity Spartan Extended Mkt Index Inv
SA US Small Company
Vanguard Balanced Index
Fidelity Nasdaq Composite Index Tracking
Fidelity Nasdaq Composite Index
•
Executives
Mr. R. Bruce Stewart
Founder
Exec. Chairman Director of Aonex Director of Unidym Director of Insert Therapeutics Inc and Director of Calando
Dr. Christopher R. Anzalone Ph.D.
Chief Exec. Officer
Pres Director Chief Exec. Officer of Calando Chief Exec. Officer of Tego Chief Exec. Officer of Nantope Chief Exec. Officer of Leonardo and Chief Exec. Officerablaris Therapeutics
Mr. Kenneth A. Myszkowski CPA
Chief Financial Officer and Principal Accounting Officer
Mr. Edward W. Frykman
Director
Chairman of Audit Committee Member of Nomination Committee Member of Compensation Committee Director of Insert Therapeutics Inc Director of Unidym Director of Aonex and Director of Calando
Dr. Mauro Ferrari Ph.D.
Director
Member of Nomination Committee and Member of Compensation Committee
Founder
Exec. Chairman Director of Aonex Director of Unidym Director of Insert Therapeutics Inc and Director of Calando
Dr. Christopher R. Anzalone Ph.D.
Chief Exec. Officer
Pres Director Chief Exec. Officer of Calando Chief Exec. Officer of Tego Chief Exec. Officer of Nantope Chief Exec. Officer of Leonardo and Chief Exec. Officerablaris Therapeutics
Mr. Kenneth A. Myszkowski CPA
Chief Financial Officer and Principal Accounting Officer
Mr. Edward W. Frykman
Director
Chairman of Audit Committee Member of Nomination Committee Member of Compensation Committee Director of Insert Therapeutics Inc Director of Unidym Director of Aonex and Director of Calando
Dr. Mauro Ferrari Ph.D.
Director
Member of Nomination Committee and Member of Compensation Committee
•
Employee Count
18
Special Offers
Competitors
ARWR earnings
Date
Actual
Expected
Prev Yr Qtr
8/12/2010
-0.01
-0.05
8/10/2009
-0.06
-0.20
5/15/2009
-0.12
-0.15
